SAREPTA THERAPEUTICS, INC. Earnings Per Share, Basic and Diluted
SAREPTA THERAPEUTICS, INC. (SRPT) reported Earnings Per Share, Basic and Diluted of -$1.20 per share for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-04.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-05-04
- SAREPTA THERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2022-03-31 was -$1.20.
- SAREPTA THERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.60.
- SAREPTA THERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$1.02.
- SAREPTA THERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$2.10.
- SAREPTA THERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2021 was -$5.15.
- SAREPTA THERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2020 was -$7.11.
- SAREPTA THERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2019 was -$9.71.
- SAREPTA THERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2018 was -$5.46.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2022-03-31 | -$1.20 10-Q · filed 2022-05-04 | |||
| 2021-12-31 | -$5.15 10-K · filed 2022-03-01 | |||
| 2021-09-30 | -$0.60 10-Q · filed 2021-11-03 | -$3.72 10-Q · filed 2021-11-03 | ||
| 2021-06-30 | -$1.02 10-Q · filed 2021-08-04 | -$3.12 10-Q · filed 2021-08-04 | ||
| 2021-03-31 | -$2.10 10-Q · filed 2022-05-04 | |||
| 2020-12-31 | -$2.40 10-K · filed 2021-03-01 | -$7.11 10-K · filed 2022-03-01 | ||
| 2020-09-30 | -$2.50 10-Q · filed 2021-11-03 | -$4.70 10-Q · filed 2021-11-03 | ||
| 2020-06-30 | -$1.93 10-Q · filed 2021-08-04 | -$2.18 10-Q · filed 2021-08-04 | ||
| 2020-03-31 | -$0.23 10-Q · filed 2021-05-05 | |||
| 2019-12-31 | -$3.16 10-K · filed 2021-03-01 | -$9.71 10-K · filed 2022-03-01 | ||
| 2019-09-30 | -$1.70 10-K · filed 2021-03-01 | -$6.54 10-Q · filed 2020-11-05 | ||
| 2019-06-30 | -$3.74 10-K · filed 2021-03-01 | -$4.85 10-Q · filed 2020-08-05 | ||
| 2019-03-31 | -$1.07 10-K · filed 2021-03-01 | |||
| 2018-12-31 | -$2.05 10-K · filed 2020-02-26 | -$5.46 10-K · filed 2021-03-01 | ||
| 2018-09-30 | -$1.15 10-K · filed 2020-02-26 | -$3.38 10-Q · filed 2019-11-07 | ||
| 2018-06-30 | -$1.67 10-K · filed 2020-02-26 | -$2.22 10-Q · filed 2019-08-07 | ||
| 2018-03-31 | -$0.55 10-K · filed 2020-02-26 | |||
| 2017-12-31 | -$0.86 10-K · filed 2020-02-26 | |||
| 2017-09-30 | -$0.78 10-Q · filed 2018-10-31 | -$0.47 10-Q · filed 2018-10-31 | ||
| 2016-12-31 | -$1.62 10-K · filed 2018-03-01 | -$5.49 10-K · filed 2019-02-28 | ||
| 2016-09-30 | -$1.18 10-K · filed 2018-03-01 | -$3.83 10-Q · filed 2017-11-01 | ||
| 2016-06-30 | -$1.35 10-K · filed 2018-03-01 | -$2.66 10-Q · filed 2016-08-09 | ||
| 2016-03-31 | -$1.31 10-K · filed 2018-03-01 | |||
| 2015-12-31 | -$1.44 10-K · filed 2017-02-28 | -$5.20 10-K · filed 2018-03-01 | ||
| 2015-09-30 | -$1.25 10-K · filed 2017-02-28 | -$3.75 10-Q · filed 2016-11-07 | ||
| 2015-06-30 | -$1.01 10-K · filed 2017-02-28 | -$2.50 10-Q · filed 2016-08-09 | ||
| 2015-03-31 | -$1.49 10-K · filed 2017-02-28 | |||
| 2014-12-31 | -$1.08 10-K · filed 2016-02-25 | -$3.39 10-K · filed 2017-02-28 | ||
| 2014-09-30 | -$0.71 10-K · filed 2016-02-25 | -$2.31 10-Q · filed 2015-11-05 | ||
| 2014-06-30 | -$0.85 10-K · filed 2016-02-25 | -$1.60 10-Q · filed 2015-08-06 | ||
| 2014-03-31 | -$0.75 10-K · filed 2016-02-25 | |||
| 2013-12-31 | -$0.23 10-K · filed 2015-02-26 | -$3.31 10-K · filed 2016-02-25 | ||
| 2013-09-30 | -$1.24 10-Q · filed 2014-11-06 | -$3.17 10-Q · filed 2014-11-06 | ||
| 2013-06-30 | -$0.60 10-K · filed 2015-02-26 | -$1.92 10-Q · filed 2014-08-07 | ||
| 2013-03-31 | -$1.32 10-K · filed 2015-02-26 | |||
| 2012-12-31 | -$5.14 10-K · filed 2015-02-26 | |||
| 2012-03-31 | -$0.78 10-Q · filed 2013-05-09 | |||
| 2011-12-31 | -$0.11 10-K · filed 2014-03-03 | |||
| 2011-09-30 | -$0.03 10-Q · filed 2011-11-08 | -$0.01 10-Q · filed 2011-11-08 | ||
| 2010-12-31 | -$1.74 10-K · filed 2013-03-15 | |||
| 2010-09-30 | -$0.07 10-Q · filed 2011-11-08 | -$0.22 10-Q · filed 2011-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |